BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
2.010
+0.270 (15.52%)
Jan 7, 2026, 10:47 AM EST - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Medicines
2.27M
Log In
Log In
Medicines Growth
64.20%
Log In
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
United States
2.27M
Log In
Log In
United States Growth
64.20%
Log In
Log In